SAVINO, Rocco
 Distribuzione geografica
Continente #
NA - Nord America 1.972
AS - Asia 926
EU - Europa 745
SA - Sud America 72
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
AF - Africa 5
Totale 3.732
Nazione #
US - Stati Uniti d'America 1.887
SG - Singapore 628
IT - Italia 354
CN - Cina 226
SE - Svezia 116
DE - Germania 101
GB - Regno Unito 78
CA - Canada 76
BR - Brasile 59
FI - Finlandia 31
IN - India 25
HK - Hong Kong 12
ES - Italia 11
CZ - Repubblica Ceca 10
RO - Romania 7
BD - Bangladesh 6
EU - Europa 6
FR - Francia 6
MX - Messico 6
PL - Polonia 6
TR - Turchia 6
AU - Australia 5
VN - Vietnam 5
CL - Cile 4
IR - Iran 4
JP - Giappone 4
NL - Olanda 4
RU - Federazione Russa 4
UA - Ucraina 4
ZA - Sudafrica 4
AT - Austria 3
AR - Argentina 2
EC - Ecuador 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
LT - Lituania 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
KI - Kiribati 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 3.732
Città #
Chandler 357
Singapore 244
Santa Clara 149
Milan 134
Princeton 134
Lawrence 130
Wilmington 79
Catanzaro 70
Ottawa 67
Ashburn 66
Munich 63
London 53
Chicago 50
Boardman 48
Des Moines 41
Shanghai 30
Turku 29
Troina 27
Guangzhou 23
Beijing 21
New York 19
The Dalles 18
Columbus 16
Norwalk 15
Seattle 15
Los Angeles 13
Naples 13
Florence 12
Wuhan 12
Falls Church 11
Hong Kong 11
Pune 10
San Francisco 10
Boston 9
Olomouc 9
Redmond 9
Cicciano 8
Council Bluffs 8
Rome 8
São Paulo 8
Shenzhen 7
Ann Arbor 6
Brooklyn 6
Hanover 6
Warsaw 6
Charlotte 5
Jiaxing 5
Parenti 5
Redwood City 5
Atlanta 4
Girona 4
Horia 4
Mountain View 4
Washington 4
West Jordan 4
Amsterdam 3
Campinas 3
Curitiba 3
Palermo 3
Phoenix 3
Rui'an 3
Tokyo 3
Vibo Valentia 3
Andover 2
Ankara 2
Assago 2
Belo Horizonte 2
Birmingham 2
Buffalo 2
Campbelltown 2
Chennai 2
Dhaka 2
Esslingen am Neckar 2
Ferrara 2
Foggia 2
Hangzhou 2
Helsinki 2
Johannesburg 2
Louisville 2
Manchester 2
Mexico City 2
Montevideo 2
Montreal 2
Nanjing 2
Nantong 2
Novokuznetsk 2
Noākhāli 2
Padova 2
Philadelphia 2
Pittsburgh 2
Quito 2
Raleigh 2
Rende 2
Rio de Janeiro 2
Squillace 2
Stockholm 2
Timisoara 2
Toronto 2
Verona 2
Wuxi 2
Totale 2.222
Nome #
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-α and Haemophilus influenzae in human bronchial epithelial cells 67
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 64
Application of proteomics and peptidomics to COPD 56
Asthma and COPD proteomics: Current approaches and future directions 52
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 52
An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity 50
Mesopore-assisted Profiling of Human Synovial Fluid 48
MALDI MS-Based Investigations Targeting SARS-CoV-2 47
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 45
A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phsphatase (SEAP) 44
A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130 43
Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer 43
A rapid and reproducible standardized procedure for MALDI-TOF profiling of gingival crevicular fluid 42
Hexagonal Mesoporous Silica as a Rapid, Efficient and Versatile Tool for MALDI-TOF MS Sample Preparation in Clinical Peptidomics Analysis: A Pilot Study. 42
Biochemical modification of an Interleukin-6 antagonist to target myeloma cells in the bone marrow microenvironment 41
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 40
Adenovirus-mediated gene transfer of a human IL-6 antagonist 40
Integrating peptidomic with lipidomic fingerprints by using mesoporous aluminosilicate and MALDI-TOF MS 40
ADENOVIRAL VECTORS ENCODING ERYTHROPOIETIN AND THEIR USE IN GENE THERAPY 40
Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung 39
The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial 39
An alternative approach for the identification of potential prostate cancer biomarkers 39
Associazione di antagonisti di IL-6 e farmaci anti-proliferativi (depositato il 10.3.2005 n. RM2005A000103) 39
Characteristics and clinical implications of the pharmacokinetic profile of ibuprofen in patients with knee osteoarthritis 39
An improved helper-dependent adenoviral vector allows persistent gene expression after i.m. delivery and overcomes pre-existing immunity to adenovirus 38
Assessment of pre-analytical and analytical variables affecting peptidome profiling of gingival crevicular fluid by MALDI-TOF mass spectrometry 38
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for biomarker discovery of Asthma and COPD 38
Biologics in severe asthma 38
Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling 37
Effect of a novel functional tomato sauce (OsteoCol) from vine-ripened tomatoes on serum lipids in individuals with common hypercholesterolemia: tomato sauce and hypercholesterolemia 37
TLR4 triggered complex inflammation in human pancreatic islets 36
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations 36
A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent 35
Association between low bone mineral density and increased α-defensin in salivary fluid among postmenopausal women 35
Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach 35
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 35
The molecular design of human IL-6 receptor antagonists 34
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non small lung cancer cells. 34
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases 34
Enhancing plasma peptide MALDI-TOF-MS profiling by mesoporous silica assisted crystallization 34
Effects of Ambrisentan in a Patient Affected by Combined Pulmonary Fibrosis and Emphysema and by Severe Pulmonary Hypertension: Clinical, Functional, and Biomolecular Findings 33
Application of MSB-MALDI-TOF-MS Technology to body fluids and Tissues peptidome profiling 33
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide 33
A PARADIGM SHIFT FOR ERYTHROPOIETIN: NO LONGER A SPECIALIZED GROWTH FACTOR, BUT RATHER THAN AN ALL-PURPOSE TISSUE-PROTECTIVE AGENT 33
PRERIBOSOMAL RNA PROCESSING IN XENOPUS-OOCYTES DOES NOT INCLUDE CLEAVAGE WITHIN THE EXTERNAL TRANSCRIBED SPACER AS AN EARLY STEP 32
Generation of IL-6 antagonists by substituting residues in helix A 32
Mesopore-assisted fingerprints of gingival crevicular fluid by MALDI-TOF mass spectrometry for monitoring inflammatory state in patients wearing fixed orthodontic appliance 32
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 32
Synergistic induction of growth arrest and apoptosis of human myeloma cells by the IL-6 super-antagonist Sant7 and Dexamethasone 31
REGULATION OF U3 SNRNA GENE-EXPRESSION 31
Gingival Crevicular Fluid Peptidome Profiling in Healthy and in Periodontal Diseases. 31
Liposomal Delivery Improves the Growth Inhibitory and Apoptotic Activity of Low Doses of Gemcitabine in Multiple Myeloma Cancer Cells 31
Cell cycle regulation and induction of apoptosis by IL-6 variants on the multiple myeloma cell line XG-1 30
A ROLE FOR U3 SMALL NUCLEAR RIBONUCLEOPROTEIN IN THE NUCLEOLUS 30
A mass spectrometry-based proteomic approach for the identification and quantification of potential biomarkers in prostate cancer. 30
Peptidomic analysis of induced sputum of asthmatic patients by MSB-MALDI-TOF-MS platform 30
ANTAGONISTS OF HUMAN INTERLEUKIN-6 THAT ARE TOTALLY INCAPABLE OF BINDING GP 130, AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOUNDS 30
EXTRA-RIBOSOMAL SPACER SEQUENCES IN TRITURUS 29
ADENOVIRAL VECTORS FOR MUTANTS OF HUMAN INTERLEUKIN 6 (HIL-6) WITH HIL-6 ANTAGONIST ACTIVITY, PHARMACEUTICAL COMPOSITIONS THEREWITH AND THEIR USES 29
Simvastatin Action Is Not Related to HDAC2 Expression in Non-Small Cell Lung Cancer (NSCLC) 29
Monovalent phage display of human Interleukin (hIL)-6: selection of superbinder variants from a complex molecular repertoire in hIL-6 D-helix 29
Effect of IL-6 variants in Multiple Myeloma:growth inhibition and induction of apoptosis in primary cells 28
Treatment with an adenoviral vector expressing the IL-6 receptor superantagonist sant7 compared with the treatment with the recombinant sant7 protein in MM cell lines 28
Identification of residues critical for biological activity and receptor binding of human Interleukin-6 28
Peptidome profiling of gingival crevicular fluid by MALDI-TOF/TOF mass spectrometry 28
Mapping the SARS-CoV-2–host protein–protein interactome by affinity purification mass spectrometry and proximity-dependent biotin labeling: A rational and straightforward route to discover host-directed anti-SARS-CoV-2 therapeutics 28
Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death 27
ANTI-TUMOUR PHARMACEUTICAL COMPOSITIONS CAPABLE OF REDUCING DRUG RESISTANCE IN TUMOUR CELLS 27
Involvement of the Arg179 in the active site of human IL-6 27
Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu in vivo model of human multiple myeloma 27
Revealing the Hidden Diagnostic Clues of Male Infertility from Human Seminal Plasma by Dispersive Solid Phase Extraction and MALDI-TOF MS 26
Liquid Cristalline Phases for the Ophthalmic Administration of Drug 26
Targeted proteomic approach in prostatic tissue: a panel of potential biomarkers for cancer detection 26
Identification of Novel Angiogenic Proteins in Multiple Myeloma Patient-Derived Endothelial Cells Using Proteome-Wide Analysis 26
C3f is a potential tool for the staging of osteoarthritis 26
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts 26
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells 26
Mass Spectrometry-Based Untargeted Approaches to Reveal Diagnostic Signatures of Male Infertility in Seminal Plasma: A New Laboratory Perspective for the Clinical Management of Infertility? 25
test di Valutazione di efficacia dei chemioterapici effettuato su tre distinte e complementari popolazioni cellulari derivate dalla massa tumorale solida 24
277 POSTER An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity 24
Designing new agonists/antagonists of growth factor receptors- The rational design of a super-antagonist of the IL-6 receptor 24
Mesoporous Beads: New Tools and Strategies in Body Fluids Proteomics 24
Combination of Interleukin-6 antagonists and antiproliferative drugs 24
MUTANT INTERLEUKIN 6 WITH IMPROVED BIOLOGICAL ACTIVITY OVER WILD INTERLEUKIN 6 24
Effects of simvastatin and rosuvastatin on RAS protein, matrix metalloproteinases and NF-kappa B in lung cancer and in normal pulmonary tissues 24
An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus 24
MALDI MS-Based Investigations for SARS-CoV-2 Detection 23
Severe Eosinophilic Asthma: from the Pathogenic role of Interleukin-5 to the Therapeutic Action of Mepolizumab. 22
USE OF MUTEINS OF WILD-TYPE CYTOKINES AS IMMUNOGENS 22
MALDI-TOF MS ANALYSIS OF LOW-ABUNDANCE PEPTIDE ENRICHED FROM BODY FLUIDS BY MESOPOROUS SILICA BEADS 21
Functionalized Mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine 21
Derivatized Mesoporous Silica Beads for MALDI-TOF MS Profiling of Human Plasma and Urine 21
Designing new agonists/antagonists of growth factor receptors - rational design of a superantagonist of the IL-6 receptor 21
Definition of a complex binding site for gp130 in human interleukin-6 (IL-6) 20
Role of p38 mitogen-activated protein kinase in asthma and COPD: Pathogenic aspects and potential targeted therapies 20
Liquid Crystalline Phases for the Ophthalmic Administration of Drug 19
Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector 19
Simultaneous extraction and rapid visualization of peptidomic and lipidomic body fluids fingerprints using mesoporous aluminosilicate and MALDI-TOF MS. 19
Simultaneous inhibition of the constitutively activated nuclear factor kappaB and of the Interleukin-6 pathways is necessary and sufficient to completely overcome apoptosis resistance of human U266 myeloma cells 19
Testosterone replacement therapy in insulin-sensitive hypogonadal men restores phosphatidylcholine levels by regulation of arachidonic acid metabolism 19
Totale 3.248
Categoria #
all - tutte 55.923
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.923


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021191 17 3 1 3 7 2 3 5 136 8 0 6
2021/2022362 2 0 10 90 37 10 17 78 30 32 55 1
2022/20231.070 267 45 50 76 117 132 5 60 169 44 83 22
2023/2024420 63 59 54 22 26 100 4 24 5 7 11 45
2024/20251.527 216 140 77 87 122 167 5 29 183 125 143 233
2025/2026160 160 0 0 0 0 0 0 0 0 0 0 0
Totale 3.832